Detailed Program

Detailed Program
 Thursday, 22 February, 2018 
14:00-18:00Registration 
18:00-19:00Welcome Reception Foyer  
   
  Friday, 23 February, 2018 
   07:30    Registration 
09:00-11:10Plenary Session 1: Opening Session
Chairs: Stevo Julius, USA, Reuven Zimlichman, Israel
 Hall A
   09:00      Greetings 
09:10Sympathetic Overdrive and the Metabolic Syndrome in Prehypertension Pathophysiology of Obesity and Insulin Resistance in Prehypertension
Stevo Julius, Division of Cardiovascular Medicine, Internal Medicine and Physiology, University of Michigan, Ann Arbor, MI, USA
 
    09:40    Prehypertension: Past, Present, Future
Reuven Zimlichman, Sackler Faculty of Medicine, Tel Aviv University, The E. Wolfson Medical Center, Holon, Israel
 
10:10Metabolic Syndrome and Microcirculation
Enrico Agabiti-Rosei, Dept. of Clinical and Experimental Sciences, University of Brescia, Italy
 
    10:40   When should Individuals with High-Normal and Normal Blood Pressure Receive Blood Pressure-Lowering Treatment?  
Alberto Zanchetti, Scientific Director, Istituto Auxologico Italiano, Milan; Emeritus Professor of Internal Medicine, University of Milan, Milan,Italy    
 
11:10-11:40Coffee Break and Posters Viewing Foyer   
11:40-13:40 Plenary Session 2: Prehypertension - Challenge and Approach
Chairs: Damiano Rizzoni, Italy, Alberto Zanchetti, Italy
 Hall A
   11:40    The Renin-Angiotensin-Aldosterone System in Prehypertension: Pathology and Intervention
Thomas Unger, CARIM - School for Cardiovascular Diseases, Maastricht University, The Netherlands
 
    12:10    Immune System and Microvascular Alterations in Obesity and Hypertension
Damiano Rizzoni, Dept. of Medical and Surgical Sciences, University of Brescia, Italy
 
    12:40    Predictive Value of Biomarkers of Fibrosis for Development of Hypertension and Cardiovascular Disease 
Daniel A. Duprez, Cardiovascular Division, University of Minnesota, Minneapolis, MN, USA
 
    13:10    How to Optimize Cardiovascular Risk Management in Hypertension. Evidence from Recent Meta- Analyses 
Gianfranco Parati, Cardiology Unit, S. Luca Hospital, Istituto Auxologico Italiano, Milan and Dept. of Medicine and Surgery, University of Milano-Bicocca, Italy
 
13:40-14:30Lunch Break and Posters Viewing  
14:30-15:30Plenary Session 3: Prehypertension - Estimation of Risk and Mechanisms
Chairs: Peter W. de Leeuw, The Netherlands, Arno Schmidt-Trucksaess , Switzerland
 Hall A
 14:30Hemodynamics of Prehypertension 
Peter W. de Leeuw, Dept. of Medicine University Hospital Maastricht, The Netherlands
 
 14:50

Clinical Importance of Exercise Capacity as a Determinant of Cardiovascular Health
Arno Schmidt-Trucksaess, Division Sports and Exercise Medicine, Medical Faculty, University Basel, Switzerland                                  

 
  15:10Pregnancy as Stress Test for Future Hypertension
Carmel McEniery, Clinical Pharmacology Unit, Addenbrooke’s Hospital, Cambridge, UK 
 
15:30-16:40 Plenary Session 4: Selected Research (Abstracts)   
Chairs: Daniel A Duprez, USA, Sekib Sokolovic 
Bosnia and Herzegovina                         
 Hall A
15:30Testosterone Therapy (Tth) Prevents Progression from Prediabetes to Type 2 Diabetes (T2dm) in Hypogonadal: 9-Year Data from a Registry Study
Farid Saad, Medical Affairs Andrology, Bayer AG, Germany
 
15:40Masked Central Hypertension and White Coat Central Hypertension and Their Association with Target Organ Damage
Chan Joo Lee, Department of Health Promotion, Severance Hospital, South Korea
 
15:50Association between Arterial Stiffness and Cardiovascular Risk Factors in a Pediatric Population
Maria Perticone, Experimental and Clinical Medicine, University Magna Graecia of Catanzaro, Italy
 
16:00Is Respiratory Modulation of Blood Pressure Enhanced in Pre-Hypertensive Humans?
Andrew Allen, Physiology, The University of Melbourne, Parkville, Victoria, Australia
 
16:10Age and Gender Influence the Hemodynamic Response to the Active Orthostatic Test
Nina Belova, Medical University of Sofia, Bulgaria
 
16:20Isolated Systolic Hypertension in the Young does not Imply an Increased Risk of Future Hypertension Needing Treatment
Lucio Mos, Emergency Department, Sant'Antonio Hospital, Italy 
 
16:30Expression of Cardiotrophin Gene in Cardiac Myopathic
Subjects
 
Saima Sharif, Zoology, Lahore College for Women University, 
Pakistan
 
16:40-17:00Coffee Break and Posters Viewing Foyer  
17:00-18:20Plenary Session 5: Prehypertension- Mechanistic Approach
Chairs: Pavel Hamet, Canada, Paolo Palatini, Italy
 Hall A
   17:00 The Morphology and Pathophysiology of the Capillaries in the Prehypertension State
Sekib Sokolovic, University Medical Center and Medical Faculty of Sarajevo Clinic for Heart, Blood Vessel and Rheumatic Diseases, Sarajevo, Bosnia and Herzegovina
 
   17:20 Arterial Distensibility, Physical Activity and the Metabolic Syndrome
Paolo Palatini, Dept. of Medicine, Vascular Medicine, University of Padova, Italy 
 
   17:40 Short Sleep Time – a Modifiable Risk Factor for Prehypertension and Hypertension?
Aleksander Prejbisz, Dept. of Hypertension, Institute of Cardiology, Warsaw, Poland
 
   18:00 New Strategies to Preserve Renal Function in Kidney Disease
Bruno Watschinger, Dept. of Medicine, University of Vienna Medical School, Vienna, Austria
 
   
 Saturday, 24 February, 2018 
   07:30 Registration Foyer  
 08:30-09:50Plenary Session 6: Prehypertension, Guidelines and Risk-Factors  
Chairs: Giuseppe Mancia, Italy, Andrzej Januszewicz, Poland
 Hall A
   08:30 High Normal Blood Pressure and New Hypertension
Guidelines
Giuseppe Mancia, Emeritus Professor of Medicine, University of Milano-Bicocca, Milan, Italy
 
   08:50Is Prehypertension a Risk Factor for Cardiovascular Disease? 
Andrzej Januszewicz, Dept. of Hypertension, Institute of Cardiology, Warsaw, Poland
 
  09:10Arterial Biomarkers in Prehypertension
Charalambos Vlachopoulos, 1st Department of Cardiology, University of Athens Medical School, Greece
 
   09:30Evidence for Increased Risk of Induced Atherosclerosis, Including Subclinical Forms in Autoimmune Disease: The Key to the Success is Multidisciplinary Approach
Ljudmila Stojanovich, Scientific Research Dept. Bezhanijska Kosa, University Medical Center, Belgrade University, Serbia 
 
09:50-10:20Coffee Break and Posters Viewing Foyer  
10:20-12:20Plenary Session 7: Prehypertension, Development and Contribution of Studies
Chairs: Guido Grassi, Italy , Yuqing Zhang, China
 Hall A
   10:20 Prehypertension in the PAMELA Study: Results and Perspectives
Guido Grassi, Dept. of Internal Medicine, University of Milano Biocca, Milan, Italy
 
   10:40 Polygenic Risk Score as a New Tool for Early Decisions in Cardio-Metabolic Syndrome
Pavel Hamet, University of Montreal and Dept. of Experimental Medicine at McGill University, Canada
 
   11:00Prehypertension: an Advanced Stage of Abnormal Blood Pressure Increasing with Age
Flávio D. Fuchs, Chief of Cardiology, Division of Cardiology, Hospital de Clínicas de Porto Alegre Universidade Federal do Rio Grande do Sul, Brazil    
 
   11:20 What we Learnt with the PREVER-PREVENTION Trial? 
Sandra Fuchs, Hospital de Clinicas de Porto Alegre, Brazil 
 
   11:40 Diurnal and Pulsatile Hemodynamics in Prehypertension
Thomas Weber, Dept. of Cardiology, Klinikum Wels-Grieskirchen, Wels, Austria
 
   12:00 What can we Learn from the Observational Studies and Clinical Trials of Prehypertension?
Yuqing Zhang, Division of Hypertension, Fu Wai Hospital, Beijing, China
 
 12:20-13:20 Lunch Break and Posters Viewing 
 13:20-14:40Plenary Session 8: Prehypertension and Diabetes
Chairs: Salvatore Novo, Italy, Guntram Schernthaner, Austria 
 Hall A
   13:20Clinical Relevance of Blood Pressure Lowering Effect of Modern Antidiabetic Drugs
Guntram Schernthaner, Dept. of Medicine I, Rudolfstiftung Hospital, Vienna, Austria
 
   13:40 Masked Hypertension in Diabetes Mellitus
Michael Bursztyn, Department of Medicine, Hypertension Unit Hadassah-Hebrew University Medical Center, Mount-Scopus, Jerusalem, Israel
 
   14:00 Influence of Insulin Resistance and Hyperinsulinism on Heart Rate Variability, Myocardial Strain and Arterial Stiffness
Salvatore Novo, Department of Sciences for Promoting Health (PROSAMI), University of Palermo, Italy
 
   14:20 Treating Hypertension in Patients with Type 2 Diabetes
Brian Rayner, Division of Nephrology & Hypertension, University of Cape Town, South Africa
 
14:40-15:30 Plenary Session 9: Selected Research (Abstracts) 
Chairs: Flávio D. Fuchs, Brazil, Pavel Hamet, Canada                         
 Hall A
14:40Clinical and Genetic Investigations of Alanine-Transaminase Levels as a Marker of NAFLD and NASH in Patients with T2D
Johanne Tremblay, University of Montreal, Canada
 
14:50Segmental Adrenal Venous Sampling can Clarify the Localization for Hyperaldosteronism in Case with Varying Diagnoses by Central Veins in Presence or Absence of Cosyntropin Stimulation
Fumitoshi Satoh, Clinical Hypertension, Endocrinology and Metabolism, Tohoku University Graduate
School of Medicine, Japan
 
15:00Management of High Blood Pressure and Cardiometabolic Risk in Primary Care: A Novel Model for Better Outcome
Bader Almustafa, Qatif-3 Primare Health Care Center, Qatif Province Primary Health Care, Qatif, Saudi Arabia
 
15:10The Influence of Metabolic Factors on Central Blood Pressure Lowering Effect of Different Combinations of Antyhypertensive Drugs
Olena Torbas, NSC Institute of Cardiology n.a. Acad. M.D. Strazhesko, Ukraine
 
15:20Hypertension and Cardiometabolic Syndrome in Real Life Setting in a Sample of Northern Italy Population
Giuseppina Patrizia Dognini, ASST Bergamo Ovest, Treviglio-Romano Hospital, Italy
 
15:30-15:50Coffee Break and Posters ViewingFoyer 
 15:50-17:10Plenary Session 10: Prehypertension and Age Groups
Chairs: Cetin Erol, Turkey, Ian B. Wilkinson, UK
 Hall A
   15:50 Markers of Early Cardiovascular Dysfunction in Prehypertension - Difference between Youth and Elderly
Bojan Jelakovic, University of Zagreb School of Medicine, University Hospital Center Zagreb, Croatia   
 
   16:10 Prehypertension in Children and Adolescents – an Overview
Mieczysław Litwin, Dept. of Nephrology and Arterial Hypertension, The Children’s Memorial Health Institute, Warsaw, Poland
 
   16:30 Why Treat Young People with Borderline Hypertension?
Ian B. Wilkinson, Clinical Pharmacology Unit, Addenbrooke’s Hospital, Cambridge, UK 
 
   16:50 Prehypertension and Metabolic Syndrome in Different Populations – Epidemiology
Cetin Erol, Ankara University, Faculty of Medicine, ibn-i Sina Hospital, Dept. of Cardiology, Ankara, Turkey
 
 17:10-17:50Plenary Session 11: Prehypertension and the Heart
Chairs: Bojan Jelakovic, Croatia, Sverre E. Kjeldsen, Norway
 Hall A
   17:10 Threshold Level of Exercise Systolic Blood Pressure at Moderate Workload in Predicting Coronary Heart Disease in Healthy Middle-aged Men
Sverre E. Kjeldsen, Dept. of Cardiology, University of Oslo Ullevaal Hospital, Norway
 
   17:30 How to Undertake the Sub Typing of Primary Aldosteronism?
CT- strategy?
AVS strategy?
Functional imaging?
Gian Paolo Rossi, Dept. of Medicine, University of Padova, Italy
 
 20:00-22:30Gala Dinner (Optional) Hall A
   
 Sunday, 25 February, 2018 
   07:30 Registration Foyer  
 08:30-09:50 

Plenary Session 12: Management of Prehypertension and Hypertension in Women of Childbearing Age
Chairs: Renata Cifkova, Czech Republic, Danuta Czarnecka, Poland

 Hall A
   08:30 Prehypertension and Hypertension in Pregnancy
Renata Cifkova, Center for Cardiovascular Prevention Charles University in Prague, First Faculty of Medicine and Thomayer Hospital Czech Republic
 
   08:50 Hypertensive Disorders of Pregnancy – Do they Influence Future Cardiovascular Health of Mother or Children?
Katarzyna Stolarz-Skrzypek, Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland
 
   09:10 Diagnostic Workup and Treatment Strategies for Prehypertension in Women of Childbearing Potential
Agnieszka Olszanecka, Poland
 
   09:30 Should Hypertensive Disorders of Pregnancy be Considered as a Prehypertension State 
Jack Blacher,Paris-Descartes University; AP-HP; Diagnosis and Therapeutic Center, Hôtel Dieu, Paris, France
 
09:50-10:50

Panel Discussion – The New ACC/AHA Guidelines on  Hypertensio
Renata Cifkova,
Czech Republic, Daniel A. Duprez, USA 
Stevo Julius, USA, Giuseppe Mancia, Italy, 
Reuvan Zimlichman, Israel

 
    10:50-11:20 Coffee Break and Posters Viewing  Foyer  
11:20-12:20Closing Session 13: Summary
Chairs: Stevo Julius, USA, Giuseppe Mancia, Italy 
Reuven Zimlichman, Israel
 Hall A
11:20 The Potential Importance of Antihypertensive Properties of Non-Antihypertensive Drugs in Patients with Prehypertension
Marcin Adamczak, Dept. of Nephrology, Transplantation and Internal Medicine, Medical University of Silesia, Poland
 
11:40 Patient Oriented Prevention of Cardiovascular Complications : New Targets ,New Diagnostic Tools, New Treatments (Hyperlipidemia , Inflammation, Hypertension and More..) 
Dov Gavish, Medicine A Wolfson Hospital, Sackler Faculty of Medicine Tel Aviv University, Israel
 
12:00 Artificial Intelligence and Hypertension: New Approach in Understanding of Possible Mechanisms
Branislav Milovanovic, Professor of Internal Medicine and Cardiology Director of Internal Clinic University Clinical Center Bezanijska Kosa Medical Faculty,University of Belgrade,Serbia 
 
12:20Summary
Stevo Julius, USA, Giuseppe Mancia, Italy
Reuven Zimlichman, Israel
 Hall A